Evidence map›Paper›PMID 27147446›Full record

ReviewCellular microbiology2016

Interaction of the Lyme disease spirochete with its tick vector.

Melissa J Caimano, Dan Drecktrah, Faith Kung, D Scott Samuels

Open access · bronzeAbstract readReview
In one paragraph

Review in Cellular microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TheInfection and immunity · 2026
    Article
  6. The BosR Is Back!Molecular microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Journal of bacteriology · 2025
    Article
  11. Article
  12. Adaptive immunity inApplied and environmental microbiology · 2024
    Article
  13. Article
  14. Article
  15. bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Hitchhiker's Guide toJournal of bacteriology · 2024
    Review
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Melissa J CaimanoDepartments of Medicine, Pediatrics, and Molecular Biology and Biophysics, UConn Health, Farmington, CT, USA.
Dan DrecktrahDivision of Biological Sciences, University of Montana, Missoula, MT, USA.
Faith KungDepartment of Veterinary Medicine, University of Maryland-College Park and Virginia-Maryland Regional College of Veterinary Medicine, College Park, MD, USA.
D Scott SamuelsDivision of Biological Sciences, University of Montana, Missoula, MT, USA.
University of Montana · USUConn Health · USVirginia–Maryland College of Veterinary Medicine · US

Funding

RpoS Regulation of Borrelia burgdorferi Genes in vivoR01AI029735 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAIMANO, MELISSA J, RADOLF, JUSTIN D · 1990 to 2022
$10.7M
BORRELIA GENE PRODUCTS CRITICAL FOR NATURAL INFECTION CYCLER01AI080615 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI PAL, UTPAL · 2009 to 2024
$5.2M
Regulation of Gene Expression in Borrelia burgdorferiR01AI051486 · NIAID · UNIVERSITY OF MONTANA · PI SAMUELS, D. SCOTT · 2003 to 2018
$5.1M
RpoS Regulation of Borrelia burgdorferi Genes in vivoR56AI029735 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RADOLF, JUSTIN D · 2012 to 2012
$536k
Essential role of Hk1/Rrp1 TCS for survival of Borrelia burgdorferi in ticksR21AI126146 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI CAIMANO, MELISSA J · 2016 to 2017
$439k
Low temperature survival of Borrelia burgdorferi in overwintering ticksR21AI088131 · NIAID · UNIVERSITY OF MONTANA · PI DRECKTRAH, DAN, SAMUELS, D. SCOTT · 2010 to 2011
$387k
Borella Gene Products Critical For Natural Infection CycleR56AI080615 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI PAL, UTPAL · 2013 to 2013
$357k
NIAID NIH HHS R01 AI029735NIAID NIH HHS R01 AI051486NIAID NIH HHS R01 AI080615NIAID NIH HHS R21 AI088131NIAID NIH HHS R21 AI126146NIAID NIH HHS R56 AI029735NIAID NIH HHS R56 AI080615
6 · The paper itself

Abstract

Borrelia burgdorferi, the causative agent of Lyme disease (along with closely related genospecies), is in the deeply branching spirochete phylum. The bacterium is maintained in nature in an enzootic cycle that involves transmission from a tick vector to a vertebrate host and acquisition from a vertebrate host to a tick vector. During its arthropod sojourn, B. burgdorferi faces a variety of stresses, including nutrient deprivation. Here, we review some of the spirochetal factors that promote persistence, maintenance and dissemination of B. burgdorferi in the tick, and then focus on the utilization of available carbohydrates as well as the exquisite regulatory systems invoked to adapt to the austere environment between blood meals and to signal species transitions as the bacteria traverse their enzootic cycle. The spirochetes shift their source of carbon and energy from glucose in the vertebrate to glycerol in the tick. Regulation of survival under limiting nutrients requires the classic stringent response in which RelBbu controls the levels of the alarmones guanosine tetraphosphate and guanosine pentaphosphate (collectively termed (p)ppGpp), while regulation at the tick-vertebrate interface as well as regulation of protective responses to the blood meal require the two-component system Hk1/Rrp1 to activate production of the second messenger cyclic-dimeric-GMP (c-di-GMP).

Indexed as

AnimalsArachnid VectorsBacterial ProteinsBorrelia burgdorferiCarbonCyclic GMPGene Expression Regulation, BacterialGuanosine PentaphosphateHost-Pathogen InteractionsLyme DiseaseTicksBacterial Proteinsbis(3',5')-cyclic diguanylic acidCarbonCyclic GMPGuanosine Pentaphosphate

Identifiers

PMID27147446
PMCPMC5067140
OpenAlexW2346625597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.